As part of this initiative, Invest UP — the state’s nodal investment promotion agency — is organising a series of global ...

The global calcium supplements market is on a steady growth trajectory, valued at USD 6.19 billion in 2025 and projected to ...

The global market for vitamin D ingredients is expected to grow at a CAGR of 7.2% between 2025 and 2035, reaching USD 3.2 ...

Dr. Philip Dormitzer, former global head of vaccine research and development at Pfizer, has been subpoenaed by the House Judiciary Committee as it investigates Pfizer’s alleged delay in the release of ...

Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...

Analysts believe that Gilead's new PrEP drug Yeztugo could reach peak sales of $4.5 billion. Not if GSK has anything to say ...

GSK PLC closed 15.86% short of its 52-week high of £16.79, which the company achieved on September 9th.

The market, which was valued at $0.85 billion in 2024, is projected to grow to $0.91 billion in 2025, representing a compound annual growth rate CAGR of 7.2%. The growth during this historic period ...

Recent health-related developments highlight significant shifts in the pharma industry and governance: France's Carmat files ...

GSK plc (NYSE: GSK) is one of the 11 best European stocks to invest in. On June 24, the company announced receipt of FDA ...